{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:46:18Z","timestamp":1787503578184,"version":"build-2736575974"},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:p>\n                    <jats:bold>Background.<\/jats:bold>\n                    Morphometry, the measurement of forms, is\n an \nancient practice. In particular, \nschizophrenic somatology was popular early in this century, but has \nbeen essentially absent from \nthe literature for over 30 years. More recently, evidence has grown to\n support the notion that \naberrant neurodevelopment may play a role in the pathophysiology of schizophrenia.\n Is the body, \nlike the brain, affected by abnormal development in these patients?\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    To evaluate global deficit in development and \nits relationship to pre-morbid function, \nheight was compared in a large group (\n                    <jats:italic>N<\/jats:italic>\n                    =226) of male \nschizophrenics and a group of healthy male \ncontrols (\n                    <jats:italic>N<\/jats:italic>\n                    =142) equivalent in parental socio-economic status.\n Patients \nin the lower quartile of \nheight were compared to those in the upper quartile of height.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    The patient group had a mean height of 177\u00b71\n cm, \nwhich was significantly shorter than the \nmean height of the control group of 179\u00b74 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0\u00b7003).\n \nThose in the lower quartile had significantly \npoorer pre-morbid function as measured by: (1) psychosocial adjustment\n using the pre-morbid \nadjustment scales for childhood and adolescence\/young adulthood, and\n \n(2) cognitive function using \nmeasures of school performance such as grades and need for special \neducation. In addition, these \nmeasures of pre-morbid function correlated significantly with height \nwhen analysed using the entire sample.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.<\/jats:bold>\n                    These findings provide further support to the\n \nidea that abnormal development may \nplay a key role in the pathophysiology of schizophrenia. Furthermore, this\n is manifested as a \nglobal deficit in growth and function resulting in smaller stature, \npoorer social skills, and deficits in cognitive abilities.\n                  <\/jats:p>","DOI":"10.1017\/s0033291797006417","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:33:33Z","timestamp":1027762413000},"page":"655-663","source":"Crossref","is-referenced-by-count":28,"title":["Morphometry in schizophrenia revisited: height and \nits relationship to pre-morbid function"],"prefix":"10.1017","volume":"28","author":[{"given":"P.","family":"NOPOULOS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"FLAUM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"ARNDT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"ANDREASEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[1998,5,1]]},"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291797006417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T15:06:15Z","timestamp":1554563175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291797006417\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["S0033291797006417"],"URL":"https:\/\/doi.org\/10.1017\/s0033291797006417","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}